Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

Prevalence of Oral HPV Infection in the United States, 2009-2010

(2012) Maura L. Gillison et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Global burden of cancers attributable to infections in 2008: a review and synthetic analysis

(2012) Catherine de Martel et al.   LANCET ONCOLOGY

Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers

(2011) J S Hocking et al.   BRITISH JOURNAL OF CANCER

Oropharyngeal cancer incidence trends: diminishing racial disparities

(2011) Linda Morris Brown et al.   CANCER CAUSES & CONTROL

Correlation between direct ELISA, single epitope-based inhibition ELISA and Pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine

(2011) Francis J. Dessy et al.   Human vaccines & immunotherapeutics

Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States

(2011) Anil K. Chaturvedi et al.   JOURNAL OF CLINICAL ONCOLOGY

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

(2011) Aimée R Kreimer et al.   LANCET ONCOLOGY

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

(2011) Matti Lehtinen et al.   LANCET ONCOLOGY

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

(2011) Anna R. Giuliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

(2011) Joel M. Palefsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Descriptive epidemiology of upper aerodigestive tract cancers in France: Incidence over 1980–2005 and projection to 2010

(2011) Karine Ligier et al.   ORAL ONCOLOGY

Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica

(2011) R. Herrero et al.   Cancer Discovery

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

(2010) Maura L. Gillison et al.   CANCER

Trends in head and neck cancer incidence in Denmark, 1978-2007: Focus on human papillomavirus associated sites

(2010) Maria Blomberg et al.   INTERNATIONAL JOURNAL OF CANCER

Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

(2010) Nubia Muñoz et al.   JNCI-Journal of the National Cancer Institute

Trends in the incidence rates of tonsil and base of tongue cancer in England, 1985–2006

(2010) VM Reddy et al.   ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma?

(2009) Anders Näsman et al.   INTERNATIONAL JOURNAL OF CANCER

Antibody Responses in Oral Fluid after Administration of Prophylactic Human Papillomavirus Vaccines

(2009) Ali Rowhani‐Rahbar et al.   JOURNAL OF INFECTIOUS DISEASES

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

(2008) Rolando Herrero et al.   VACCINE